After reading a long discussed thread on TA I thought it opportune to start discussing Fundamentals, after all AJX has been derisked hugely during 2015.
I have run my F.A.K.E. Company analisis tool over AJX and arrived at a revenue figure that AJX 'needs' to attract as revenue for 2016.
That figure is $12 - $14m to be able to justify it's current share price of .80c.
Arrived at after being very generous with a P/E ratio.
Should very interesting next two quarterlies.
After all it is Fundamentals that dictate whether a company rises or falls
- Forums
- ASX - By Stock
- FA Discussion
After reading a long discussed thread on TA I thought it...
Featured News
Add AJX (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.73M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.0¢ | $17.32K | 1.728M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1535720 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 6314 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1535720 | 0.010 |
6 | 519629 | 0.009 |
3 | 511000 | 0.008 |
2 | 240000 | 0.007 |
3 | 516888 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 6314 | 2 |
0.014 | 137511 | 2 |
0.015 | 129929 | 2 |
0.016 | 5328505 | 2 |
0.017 | 321118 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AJX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online